Gilead Sciences announced in a press release Wednesday that its COVID-19 drug remdesivir reduces hospitalizations by 87% in high-risk patients.
The study consisted of 562 patients who were randomly given either remdesivir to a placebo. The company said that it saw an 87% reduction in hospitalizations after day 28, according to the press release. The trial was supposed to have over 1,000 subjects but the Gilead halted enrollment after other COVID-19 drugs became readily available.
Read More
A large study led by the World Health Organization suggests that the antiviral drug remdesivir did not help hospitalized COVID-19 patients, in contrast to an earlier study that made the medicine a standard of care in the United States and many other countries.
The results announced Friday do not negate the previous ones, and the WHO study was not as rigorous as the earlier one led by the U.S. National Institutes of Health. But they add to concerns about how much value the pricey drug gives because none of the studies have found it can improve survival.
Read More
The United States has secured nearly the entire global supply of remdesivir, a drug that has been effective in fighting coronavirus.
Remdesivir, which is manufactured by American pharmaceutical giant Gilead, has proven to help patients with coronavirus recover faster, according to The Guardian. The U.S. Department of Health and Human Services (HHS) secured more than 500,000 doses of the drug, accounting for the vast majority of Gilead’s July, August and September supply, according to a Monday press release.
Read More
Remdesivir, an antiviral medication that was developed by the biopharmaceutical company Gilead Sciences, has been widely touted as the most promising drug to treat COVID-19, even though – so far – the new and expensive drug does not seem to be terribly effective at fighting the disease.
The anti-malaria drug hydroxychloroquine, on the other hand, is cheap, has been used safely for decades, and has shown great promise as a weapon in the fight against the coronavirus – yet after President Trump mentioned it as a promising potential treatment for the disease, the media immediately blasted him for touting an “unproven” and potentially unsafe drug.
Read More
Dr. Anthony Fauci on Wednesday said a study of the antiviral drug remdesivir showed promising signs for treatment of coronavirus.
Read More
COVID-19 patients treated with the drug remdesivir recovered quickly from severe illness in a study conducted at the University of Chicago, according to the medical website STAT News.
Read More